Active Biotech AB (ACTI) — Tangible Net Worth Ratio
Active Biotech AB (ACTI) has a Tangible Net Worth Ratio of 99.6% as of March 2026. This metric is calculated by deducting intangible assets (Skr200.00K) from net assets (Skr47.20 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ACTI net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Active Biotech AB Tangible Net Worth Ratio (2000–2025)
This chart shows how Active Biotech AB's Tangible Net Worth Ratio has changed across 26 annual periods from 2000 to 2025. As of March 2026, the ratio stands at 99.6%, reflecting net assets of Skr47.20 Million with intangible assets of Skr200.00K SEK. For live market cap and overall valuation, see Active Biotech AB stock valuation.
Annual Tangible Net Worth Ratio for Active Biotech AB (2000–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Active Biotech AB from 2000 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore ACTI capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.6% | Skr55.60 Million | Skr245.00K | Skr70.20 Million | ▲ +0.3 pp |
| 2024 | 99.2% | Skr32.07 Million | Skr245.00K | Skr43.20 Million | ▲ +0.0 pp |
| 2023 | 99.2% | Skr30.67 Million | Skr245.00K | Skr44.05 Million | ▼ -0.1 pp |
| 2022 | 99.3% | Skr34.51 Million | Skr245.00K | Skr51.01 Million | ▼ -0.7 pp |
| 2021 | 100.0% | Skr46.67 Million | Skr0.00 | Skr56.80 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr22.11 Million | Skr0.00 | Skr32.16 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Skr53.78 Million | Skr0.00 | Skr66.95 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Skr87.92 Million | Skr0.00 | Skr302.43 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Skr77.68 Million | Skr0.00 | Skr303.81 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Skr182.56 Million | Skr0.00 | Skr412.88 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Skr180.60 Million | Skr0.00 | Skr449.44 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Skr405.31 Million | Skr0.00 | Skr722.52 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr405.41 Million | Skr0.00 | Skr767.81 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr339.92 Million | Skr0.00 | Skr696.74 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Skr501.99 Million | Skr0.00 | Skr858.52 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Skr181.76 Million | Skr0.00 | Skr503.10 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Skr188.64 Million | Skr0.00 | Skr498.50 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr163.61 Million | Skr0.00 | Skr472.95 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Skr189.57 Million | Skr0.00 | Skr489.54 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Skr60.36 Million | Skr0.00 | Skr462.40 Million | ▲ +0.0 pp |
| 2005 | 100.0% | Skr176.81 Million | Skr0.00 | Skr567.86 Million | ▲ +0.0 pp |
| 2004 | 100.0% | Skr162.30 Million | Skr0.00 | Skr312.89 Million | ▲ +0.0 pp |
| 2003 | 100.0% | Skr289.58 Million | Skr0.00 | Skr345.40 Million | ▲ +0.0 pp |
| 2002 | 100.0% | Skr380.27 Million | Skr0.00 | Skr467.50 Million | ▲ +0.0 pp |
| 2001 | 100.0% | Skr678.78 Million | Skr0.00 | Skr747.74 Million | ▲ +7.3 pp |
| 2000 | 92.7% | Skr646.03 Million | Skr47.14 Million | Skr868.95 Million | — |